Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 55 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT05142189
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
- Locations
-
- University of Kentucky Chandler Medical Center Lexington, Kentucky, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Ohio State University Columbus, Ohio, United States
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
NCT03356782
- Conditions
- Bone Diseases, Bone Neoplasms, Diabetes Mellitus, Insulin-Dependent, 12, +12 more
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
NCT06564623
- Conditions
- Biliary Tract Cancers, Biliary Tract Diseases, Biliary Tract Neoplasms, +8 more
- Locations
-
- SKCCC Johns Hopkins Medical Institution Baltimore, Maryland, United States
IMMUNO-FIT Observational Study
NCT07354971
- Conditions
- Chemically-Induced Disorders, Diabetes Mellitus, Insulin-Dependent, 12, Drug-Related Side Effects and Adverse Reactions, +4 more
- Locations
-
- University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
NCT07410975
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
NCT05139706
- Conditions
- Autoimmune Diseases, Cancer, Diabetes Mellitus, Insulin-Dependent, 12, +7 more
- Locations
-
- Jewish General Hospital Montreal, Quebec, Canada
NCT06494995
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Diabetes Mellitus, Insulin-Dependent, 12, +7 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT06258304
- Conditions
- Advanced or Metastatic Solid Tumor Malignancies, Diabetes Mellitus, Insulin-Dependent, 12
- Locations
-
- National Cancer Institute Bethesda, Maryland, United States
Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
NCT07476326
- Conditions
- Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms, +10 more
- Locations
-
- High Technology Hospital Medcenter Batumi, Georgia
- JSC Vian Kutaisi, Georgia
- Institute of Clinical Oncology - Lubliana Street Tbilisi, Georgia
- Israel-Georgian Medical Research Clinic Helsicore Tbilisi, Georgia
PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC
NCT07416058
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
- Locations
-
Not specified
NCT07243951
- Conditions
- Combined Hepatocellular-cholangiocarcinoma, Diabetes Mellitus, Insulin-Dependent, 12, Digestive System Diseases, +5 more
- Locations
-
Not specified
NCT07131501
- Conditions
- Adenocarcinoma, CTLA-4, Carcinoma, +14 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
NCT07128251
- Conditions
- Adenocarcinoma, CTLA-4, Carcinoma, +14 more
- Locations
-
Not specified
NCT07004335
- Conditions
- Advanced Melanoma, Bevacizumab, CTLA-4, +4 more
- Locations
-
- The Fourth Hospital of Hebei Medical University Shijiazhuang, China
A Phase I, First-in-Human Study of GB268 (PD-1/CTLA-4/VEGF Trispecific Antibody) in Advanced Solid Tumors
NCT06934616
- Conditions
- Diabetes Mellitus, Insulin-Dependent, 12, Solid Tumor Cancer
- Locations
-
Not specified
NCT04740307
- Conditions
- Advanced Hepatocellular Carcinoma, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body
- Locations
-
- City of Hope Comprehensive Cancer Center ( Site 0002) Duarte, California, United States
- Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - GI and Immunology ( Site 0013) Baltimore, Maryland, United States
- Icahn School of Medicine at Mount Sinai ( Site 0009) New York, United States
- Oregon Health and Science University ( Site 0006) Portland, Oregon, United States
NCT05773105
- Conditions
- Advanced Hepatocellular Carcinoma, Diabetes Mellitus, Insulin-Dependent, 12
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT04305054
- Conditions
- Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms, +11 more
- Locations
-
- The Angeles Clinic and Research Institute ( Site 2009) Los Angeles, California, United States
- UCLA Hematology & Oncology ( Site 2004) Los Angeles, California, United States
- Providence Saint John's Health Center ( Site 2010) Santa Monica, California, United States
- University of Colorado, Anschutz Cancer Pavilion ( Site 2012) Aurora, Colorado, United States
NCT04253080
- Conditions
- Cutaneous Melanoma, Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, +11 more
- Locations
-
- Dermatology department Paris, Île-de-France Region, France
NCT03293784
- Conditions
- Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms, +10 more
- Locations
-
- Institut Claudius Regaud IUCT-ONCOPOLE Toulouse, France